Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study
- 10 August 2012
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 33 (5) , 1695-1700
Abstract
Prognosis of patients with pancreas cancer is very poor. The aim of the study was to test the significance of laboratory parameters in the prognosis of patients with pancreas cancer. The studied group included 57 patients (31 men, 26 women, mean age 65 ± 9 years). Blood was collected at the time of diagnosis of pancreas cancer and basic laboratory parameters, including nutritional and inflammatory markers and tumour markers were measured. Patients were followed up until death (median survival 147 days). Ferritin, iron, albumin, prealbumin, cholinesterase, haemoglobin, C-reactive protein, alkaline phosphatase and carcinoembryonic antigen were significant for patients’ prognosis in univariate analysis while CA 19-9, bilirubin, liver, pancreas and kidney tests and lipids were not. Multivariate Cox regression demonstrated ferritin, iron and albumin as independent mortality predictors (RR (95%CI), per standard deviation: ferritin 1.497(1.215–2.241), p = 0.002; albumin, 0.716(0.521–0.977), p = 0.035; iron, 0.678(0.504–0.915), p = 0.010). Iron correlated significantly with albumin (r = 0.397, p = 0.002) but neither iron nor albumin correlated with ferritin. Patients who survived 100 days had significantly lower ferritin (median 239 μg/l vs. non-survivors 435 μg/l, p = 0.014), significantly higher albumin but the difference in serum iron was not quite significant. ROC analysis for ferritin revealed AUC for 100 days survival of 0.710, p = 0.007 (and 0.725, p = 0.004 for 200 days survival). AUC for albumin for 100 days survival was not significant (p = 0.073). This study points out ferritin as an independent mortality predictor in patients with pancreas cancer. High serum levels of ferritin at the time of diagnosis of pancreas cancer indicate bad prognosis of the patient.Keywords
This publication has 20 references indexed in Scilit:
- The Glasgow Prognostic Score Is a Good Predictor of Treatment Outcome in Patients with Unresectable Pancreatic CancerChemotherapy, 2010
- Prognostic Factors for Survival in Patients With Unresectable Pancreatic CancerPancreas, 2010
- Nuclear ferritin: A new role for ferritin in cell biologyBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status reportAnnals of Oncology, 2009
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 studyThe Lancet Oncology, 2007
- The Ratio of Metastatic/Resected Lymph Nodes is an Independent Prognostic Factor in Patients With Node-positive Pancreatic Head CancerPancreas, 2006
- Ferritin Contributes to Melanoma Progression by Modulating Cell Growth and Sensitivity to Oxidative StressClinical Cancer Research, 2005
- Influence of Surgical Resection and Post-Operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled TrialDigestive Surgery, 2005
- Combined Evaluation of Serum Ribonuclease and Ferritin: Any Advantages in Pancreatic Cancer Diagnosis?Oncology, 1984
- Serum Ferritin in Pancreatic DiseaseDigestion, 1982